Trials (Uppsala University Hospital): Revision history

15 December 2025

• curprev 16:5116:51, 15 December 2025‎ Francine talk contribs‎ 128,222 bytes +190‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 128,032 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 17:0717:07, 4 December 2025‎ Larysse talk contribs‎ 126,331 bytes +48‎ No edit summary undo

2 December 2025

• curprev 14:0114:01, 2 December 2025‎ Lucas talk contribs‎ m 126,283 bytes +90‎ Update categories. undo

5 December 2023

• curprev 17:5617:56, 5 December 2023‎ Francine talk contribs‎ 126,193 bytes +126,193‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Uppsala University Hospital page '''NCTID''': NCT00036556 '''Title''': Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer '''Study Summary''': This study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer. '''Sponsor''': Abbott '''Intervention''': Atrasentan '''Start Date''': 2001-06 '''..."